首页> 外文OA文献 >A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned
【2h】

A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned

机译:非甾体抗炎药物风险意识的共享决策的组随机试验:主要结果和经验教训

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

RATIONALE, AIMS AND OBJECTIVES: Frequent use and serious adverse effects related to non-steroidal anti-inflammatory drugs (NSAIDs) underscore the need to raise patient awareness about potential risks. Partial success of patient- or provider-based interventions has recently led to interest in combined approaches focusing on both patient and physician. This research tested a shared decision-making intervention for increasing patient-reported awareness of NSAID risk.METHODS: A group randomized trial was performed in Alabama from 2005 to 2007. Intervention group doctor practices received continuing medical education (CME) about NSAIDs and patient activation tools promoting risk assessment and communication during visits. Comparison group doctor practices received only CME. Cross-sectional data were collected before and after the intervention. Generalized linear latent and mixed models with logistic link tested relationships among the intervention, study phase, intervention by study phase interaction and patient-reported awareness of risks with either prescription or over-the-counter (OTC) NSAIDs.RESULTS: Three hundred and forty-seven patients at baseline and 355 patients at follow-up participated in this study. The intervention [adjusted odds ratio (AOR)=0.74, P=0.248], follow-up study phase (AOR=1.31, P=0.300) and intervention by study phase interaction (AOR=0.98, P=0.942) were not significantly associated with patient-reported awareness of any prescription NSAID risk. Follow-up study phase was associated with increased odds of reporting any OTC NSAID risk awareness (AOR=2.99, P u3c 0.001), but the patient activation intervention and intervention by study phase interaction were not significantly associated with patient-reported awareness of any OTC NSAID risk (AOR=0.98, P=0.929; AOR=0.87, P=0.693, respectively).CONCLUSIONS: Our point-of-care intervention encouraging shared decision making did not increase NSAID risk awareness.
机译:理由,目标和目标:频繁使用和与非甾体类抗炎药(NSAIDs)相关的严重不良影响(NSAIDS)强调需要提高患者对潜在风险的认识。患者或提供者的干预措施的部分成功最近导致对关注患者和医生的合并方法感兴趣。这项研究测试了一项共同决策干预,以提高患者报告的NSAID风险的认识。方法:从2005年到2007年在阿拉巴马州进行了组随机试验。干预组医生做法接受了关于NSAID和患者激活的持续医学教育(CME)工具在访问期间促进风险评估和沟通。比较组医生实践只收到CME。在干预之前和之后收集横截面数据。具有物流链路的广义线性潜在和混合模型在介入,研究阶段,学习阶段互动和患者的干预之间进行了关系,患者报告的风险的意识与处方或柜台上的风险(OTC)NSAIDS。结果:三百四十 - 在基线和355名随访中的患者参加了这项研究。干预[调整的差距(AOR)= 0.74,p = 0.248],随访研究阶段(AOR = 1.31,P = 0.300)和通过研究相互作用的干预(AOR = 0.98,P = 0.942)没有显着相关患者报告对任何处方风险的认识。随访研究阶段与报告任何OTC NSAID风险意识的可能性增加有关(AOR = 2.99,P U3C 0.001),但研究相互作用的患者激活干预和干预没有显着与患者报告的任何意识相关联OTC NSAID风险(AOR = 0.98,P = 0.929; AOR = 0.87,P = 0.693,P = 0.693,P = 0.693,Conclusions:我们的护理点干预鼓励共享决策并没有增加NSAID风险意识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号